scispace - formally typeset
F

Francesca Velotti

Researcher at Tuscia University

Publications -  54
Citations -  3739

Francesca Velotti is an academic researcher from Tuscia University. The author has contributed to research in topics: Cytotoxic T cell & Hydroxytyrosol. The author has an hindex of 22, co-authored 52 publications receiving 2472 citations. Previous affiliations of Francesca Velotti include University of L'Aquila & Sapienza University of Rome.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Consensus guidelines for the detection of immunogenic cell death

Oliver Kepp, +81 more
- 29 Oct 2014 - 
TL;DR: Strategies conceived to detect surrogate markers of ICD in vitro and to screen large chemical libraries for putative I CD inducers are outlined, based on a high-content, high-throughput platform that was recently developed.
Journal ArticleDOI

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Abhishek D. Garg, +53 more
- 20 Nov 2015 - 
TL;DR: The main molecular, immunological, preclinical, and clinical aspects of ICD are summarized and tabulate in an attempt to capture the essence of this phenomenon, and identify future challenges for this rapidly expanding field of investigation.
Journal ArticleDOI

Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy.

Donatella D’Eliseo, +1 more
- 26 Jan 2016 - 
TL;DR: This analysis can allow a better comprehension of the potential cytotoxic therapeutic role of n-3 PUFAs against cancer, providing specific information and support to design future pre-clinical and clinical studies for a better use ofn-3PUFAs in cancer therapy, mainly combinational therapy.
Journal ArticleDOI

Dietary ω-3 Polyunsaturated Fatty Acid DHA: A Potential Adjuvant in the Treatment of Cancer

Nicolò Merendino, +5 more
- 23 May 2013 - 
TL;DR: Current knowledge supporting the potential use of DHA for the enhancement of the efficacy of anticancer treatments in relation to its ability to enhance the uptake of antic cancer drugs, regulate the oxidative status of tumor cells, and inhibit tumor cell invasion and metastasis is reviewed.